What happened Shares of Endo International (NASDAQ: ENDP) were soaring 23.2% higher as of 11:15 a.m. EDT on Tuesday. The big jump came as investors anticipated that the company would reach a settlement with several Tennessee counties involved in an opioid-related lawsuit. So what District Attorney General Barry Staubus told Tennessee News Channel 11 (WJHL) that Endo has extended an offer to settle the case. Jury selection was scheduled to begin in a few days. Officials in Greene, Sullivan, and Washington counties are expected to hold public meetings tomorrow to review the settlement offer. Image source: Getty Images. No financial details of the settlement have been announced. Endo hasn't issued a public statement on the matter at the time of this writing. However, the company stated on July 15 that it was "exploring all of its legal options" in the case. Investors are clearly optimistic, though, about the prospects of Endo avoiding a trial based on today's big gain for the pharmaceutical stock. The company is the only defendant in the litigation that hasn't filed for bankruptcy. Now what Even if Endo reaches a settlement with the Tennessee counties, the company's legal battles related to its opioid drugs are far from over. New York Attorney General Letitia James said today that three major drug distributors settled with the state of New York and two large counties in the state. However, a trial is still scheduled with Endo and two other drugmakers. 10 stocks we like better than Endo InternationalWhen our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* They just revealed what they believe are the ten best stocks for investors to buy right now... and Endo International wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of June 7, 2021 Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.Source